Project Number EUJPND-CIHR-Schlossmacher-469 Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Year 2016 View Full Project Details for Cathepsin D Activation: A Target to Reduce Alpha-Synuclein Pathology in a Parkinson's Model Research Categorization Primary Disease / Condition Lewy Body Dementias CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) i. Proteostasis/Proteinopathies Researcher and Organization Principal Investigator Schlossmacher, Michael G Principal Investigator First Name Michael G Principal Investigator Last Name Schlossmacher Awardee Organization Ottawa Hospital Research Institute Contact PI Country Canada Project Detail FY Overall Cost $111,080 Funding Organization Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Organization Country Canada Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
